Under the liquidity contr Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical ...
In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Inventiva (IVA – Research Report), with a price ...
Shares of NASDAQ IVA opened at $2.84 on Friday. Inventiva has a 12-month low of $1.53 and a 12-month high of $4.50. The company has a 50-day moving average of $2.33 and a 200 day moving average of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback